Thermo Fisher Scientific Publishes New Poster Illustrating the Benefits of Integrating Comprehensive Solutions for Biobanks
4 October 2010 | By The Scott Partnership
Thermo Fisher Scientific Inc., is offering a new technical poster...
List view / Grid view
News
New outcomes study for ticagrelor (BRILINTA™) to examine longer-term treatment for post- ACS patients
1 October 2010 | By AstraZeneca
AstraZeneca announced outcomes study for the investigational oral antiplatelet, ticagrelor (BRILINTA™/BRILIQUE™)...
From macro to micro with the Tecan Cavro® Mini Sample Processor
29 September 2010 | By kdm communications limited
IntegenX, Inc., has used Tecan’s Cavro® Mini Sample Processor (MSP) 9250 as the basis for an automated Sanger sequencing sample preparation platform...
AstraZeneca initiates phase III clinical development of fostamatinib for the treatment of rheumatoid arthritis
29 September 2010 | By AstraZeneca
AstraZeneca announced the enrollment of the first patient in the phase III clinical development programme for fostamatinib...
Creabilis Appoints Dr. Eliot Forster as its New Chief Executive Officer
29 September 2010 | By Citigate Dewe Rogerson
Creabilis SA, today announced the appointment of Eliot Forster as its new Chief Executive Officer...
Results of Zibotentan Phase III trial in castration resistant prostate cancer
27 September 2010 | By AstraZeneca
AstraZeneca announced that a study evaluating zibotentan for the treatment of men with metastatic CRPC did not show improvement in the primary endpoint of overall survival...
New version of Copley Scientific’s inhaler testing software adds automatic data import from Waters Empower
27 September 2010 | By Kapler Communications
Copley Scientific has introduced a new version of its widely used CITDAS...
BRILIQUE (ticagrelor) receives positive opinion from European CHMP for the treatment of Acute Coronary Syndromes
24 September 2010 | By AstraZeneca
AstraZeneca announced that the CHMP issued a positive opinion on the marketing authorisation...
Synexus puts Medical Affairs at the top of its agenda with new Chief Medical Officer
23 September 2010 | By Synexus
Synexus has appointed Dr Glynis Neagle as Chief Medical Officer...
Tecan’s Freedom EVO® automates tropical disease research
23 September 2010 | By kdm communications limited
The Clinical Pharmacology Department has chosen Tecan’s Freedom EVO® platform to automate research into the pharmacology of anti-malarial and anti-influenza drugs...
Shire plc becomes OBN’s first Corporate Patron
23 September 2010 | By Citigate Dewe Rogerson
OBN, announced today that global specialty pharmaceutical company Shire has become the network’s first Corporate Patron...
bioMérieux Awarded NHSBT Contract for Bacterial Screening of Platelets
20 September 2010 | By kdm communications limited
bioMérieux, was chosen by National Health Service Blood and Transplant (NHSBT) for bacterial screening of platelets in England and North Wales...
Creabilis Appoints George F. Horner III as its Chairman
15 September 2010 | By Citigate Dewe Rogerson on behalf of Creabilis SA
Creabilis SA, today announced the appointment of George F. Horner III as its Chairman...
Sigma® Life Science to Supply Oligonucleotides to Research Councils UK
14 September 2010 | By kdm communications limited
Sigma® Life Science, signed a 3 year contract with RCUK Shared Services Centre to be a prefered supplier for synthetic oligonucleotides...
Rexahn Pharmaceuticals Announces the Appointment of Peter Brandt and Richard Kivel to Board of Directors
13 September 2010 | By Rexahn Pharmaceuticals
Rexahn Pharmaceuticals, Inc. announced the appointment of Peter Brandt and Richard Kivel to the company's board of directors...
